中枢白细胞介素-1系统及信号转导研究进展

中枢白细胞介素 1(centralinterleukin 1,IL 1)以及功能和结构相关的分子已构成相对独立的中枢IL 1系统 (IL 1system)。IL 1系统的研究不断深入 ,新成员及其功能不断被发现 ,极大地扩展了该系统新老成员的生物学作用、信号转导通路 ,以及相互之间的联系。本文总结了近几年关于中枢IL 1系统的研究进展 ,包括IL 1系统新成员、信号转导通路和新的信号分子 ,以及IL 1系统与某些生理过程或病理生理过程的关系。     

白细胞介素2的中枢作用

白细胞介素２（ＩＬ－２）不仅是重要的免疫调节因子,而且具有重要的中枢调节作用。业已证实,脑内存在着ＩＬ－２和ＩＬ－２受体（ＩＬ－２Ｒ）,ＩＬ－２能明显地影响神经元和神经胶质细胞的生长,并能作用于下丘脑－垂体－肾上腺轴而影响内分泌,还能对电生理、行为等产生影响。本文简述了ＩＬ－２的中枢作用。     

白细胞介素—2的中枢镇痛作用

本实验采用侧脑室给药,以钾离子透入法引起大鼠甩尾反应为指标,测定动物的痛阈,发现白细胞介素－２具有显著提高大鼠痛阈的作用,此作用能被抗ＩＬ－２单克隆抗体所阻断。纳洛酮能反转ＩＬ－２的镇痛作用,表明其作用机理与阿片受体有关。     

中枢神经系统内白细胞1作用的研究进展

白细胞介素１（ＩＬ－１）作为细胞因子,一般认为其主要功能是介导非特异性免疫反应,促进未成熟的Ｔ、Ｂ淋巴细胞增殖、分化和生长等。近年实验证明,ＩＬ－１及其受体也存在于中枢神经系统（ＣＮＳ）内,并且对ＣＮＳ中某些神经元和胶质细胞以及整体的生理功能具有调控艇。     

白细胞介素－2的中枢镇痛作用

本实验采用侧脑室给药,以钾离子透入法引起大鼠甩尾反应为指标,测定动物的痛阈,发现白细胞介素－２（ＩＬ－２）具有显著提高大鼠痛阈的作用,此作用能被抗ＩＬ－２单克隆抗体所阻断。纳洛酮能反转ＩＬ－２的镇痛作用,表明其作用机理与阿片受体有关。     

白细胞介素-1的分子生物学

本文先简述了IL-1的来源及生物功能,接着对不同生物的IL-1α、IL-1β前体蛋白进行了同源性比较和分析,然后就人类IL-1β分子前结构与功能的关系及空间结构进行了探讨。     

胚胎植入中白细胞介素-1的信号转导及其生理作用

本文论述了白细胞介素－１（ＩＬ－１）的信号转导通路及其在胚胎植入中的调节作用。指出：植入过程中,ＩＬ－１起着十分重要的作用,但并非唯一的重要因子,成功的胚胎植入需要多种细胞因子的协同作用。     

白细胞介素-6在肝再生中的作用

白细胞介素-6(IL-6)是一种多功能的细胞因子。近年来发现,它是启动肝细胞增殖的早期信号中不可缺少的组成部分,在肝再生中有重要作用。现对IL-6在肝再生中的作用及可能机制进行综述,为肝脏疾病的治疗提供新的思路。     

白细胞介素-1家族细胞因子研究进展

随着老龄化时代的到来,各种自身免疫性疾病和肿瘤性疾病更加频繁发生,给人类的生命健康和生活质量带来了影响,其中白细胞介素-1(interleukin-1, IL-1)家族成员在这些疾病中起着重要作用。目前,对IL-1家族的研究发展迅速,已鉴定了11种细胞因子和10种受体,其生物学功能、与疾病的关系及应用越来越受到各国科学家的青睐。现对IL-1家族细胞因子、受体、信号通路和生物学功能作一概述,并展望IL-1家族在药物研发和临床治疗方面的应用前景。     

Role of interleukin-1 in stress responses

Recently, the central roles of interleukin-1 (IL-1) in physical stress responses have been attracting attention. Stress responses have been characterized as central neurohormonal changes, as well as behavioral and physiological changes. Administration of IL-1 has been shown to induce effects comparable to stress-induced changes. IL-1 acts on the brain, especially the hypothalamus, to enhance release of monoamines, such as norepinephrine, dopamine, and serotonin, as well as secretion of corticotropin-releasing hormone (CRH). IL-1-induced activation of the hypothalamo-pituitary-adrenal (HPA) axis in vivo depends on secretion of CRH, an intact pituitary, and the ventral noradrenergic bundle that innervates the CRH-containing neurons in the paraventricular nucleus of the hypothalamus. Recent studies have shown that IL-1 is present within neurons in the brain, suggesting that IL-1 functions in neuronal transmission. We showed that IL-1 in the brain is involved in the stress response, and that stress-induced activation of monoamine release and the HPA axis were inhibited by IL-1 receptor antagonist (IL-1Ra) administration directly into the rat hypothalamus. IL-1Ra has been known to exert a blocking effect on IL-1 by competitively inhibiting the binding of IL-1 to IL-1 receptors. In the latter part of this review, we will attempt to describe the relationship between central nervous system diseases, including psychological disorders, and the functions of IL-1 as a putative neurotransmitter.     

The effect of chronic stress on prenatal development of the central nervous system

Abstract

The survival of developing embryos depends on the control and maintenance of homeostasis. Stress caused by chronic immobilization during pregnancy in rats may alter the normal development of the nervous system and increase susceptibility to psychiatric disorders. We investigated the effects of chronic stress on cell proliferation in the forebrains of embryos at 12 days of gestation, and in the hippocampus, dentate gyrus and cortex in embryos at 17 and 21 days of gestation. We examined serial sections of the embryonic brains of control and stressed rats at days 12, 17 and 21 of gestation. Brain sections were immunolabeled with anti-PCNA and stereological analysis was performed on 540 images. The results showed no statistical differences on days 12 and 17 of gestation in the proliferation area of the structures studied, whereas on day 21 of gestation, proliferation decreased in the cortex and dentate gyrus of embryos of the stressed group. These changes were related to decreased prolactin and increased corticosterone concentrations in the plasma.     

Effects of temperature stress on NO-synthase and tyrosine hydroxylase activities in the central nervous system of bivalve molluscs

Effects of temperature stress on activities of NO-synthase (NOS) and tyrosine hydroxylase (TH) in the CNS of two species of bivalve molluscs, Mizuchopecten yessoensis and Chlamys farreri nipponensis (Pectinidae) were studied using NADPH-diaphorase histochemistry and immunocytochemistry. General and specific peculiarities in distribution and relative proportion of TH- and NO-containing neurons in the CNS nerve ganglia were revealed in norm and under stress at 30°C for 10, 30, and 60 min. The initial stress stage (for 10 min) has been found to be accompanied by an increase of the relative content of TH-positive neurons in some CNS areas of both mollusc species. In intact Chlamys farreri nipponensis, the presence of NOS in the CNS and its significant activation under temperature stress might have possibly been an important neuroprotective component of stress reaction in some mollusc species.     

Effect of elevated temperature and of hypoxia on NO activity in the central nervous system of bivalve molluscs

By light and electron microscopy methods the effect of changes of environmental conditions on the state of the nitroxidergic system has been studied in molluscs on the background of action of elevated temperature and hypoxia. Analysis is performed of biological effect of isolated and combined effects of the studied factors on dynamics of NO synthesis. A higher resistance of CNS neurons to the combined action of hyperthermia and hypoxia is revealed in molluscs with the initially high level of nitrogen oxide production. In molluscs with the initially low level of development of the nitroxidergic system, induction of NO formation in stress has been found to be accompanied by a change of morphology of nervous structures. It is suggested that nitrogen oxide participates in evolutionary established mechanisms of protection of mollusc nerve cells from hypoxia, while the initial high level of NO production reflects larger adaptational possibilities characteristic of these organisms.     

PPARβ在中枢神经系统中的作用研究进展

PPARβ是配体活化的核转录因子,属核受体超家族成员。PPARβ在哺乳动物体内表达十分丰富,日前对PPARβ的研究比较少,但现有的研究表明PPARβ可能参与了机体多种生理和病理过程。本文将对PPARβ的生物学特征及其在中枢神经系统中的意义作一综述。     

Age-associated changes in central nervous system glycerolipid composition and metabolism

In this review, changes in brain lipid composition and metabolism due to aging are outlined. The most striking changes in cerebral cortex and cerebellum lipid composition involve an increase in acidic phospholipid synthesis. The most important changes with respect to fatty acyl composition involve a decreased content in polyunsaturated fatty acids (20:4n-6, 22:4n-6, 22:6n-3) and an increased content in monounsaturated fatty acids (18:1n-9 and 20:1n-9), mainly in ethanolamine and serineglycerophospholipids. Changes in the activity of the enzymes modifying the phospholipid headgroup occur during aging. Serine incorporation into phosphatidylserine through base-exchange reactions and phosphatidylcholine synthesis through phosphatidylethanolamine methylation increases in the aged brain. Phosphatidate phosphohydrolase and phospholipase D activities are also altered in the aged brain thus producing changes in the lipid second messengers diacylglycerol and phosphatidic acid.     

New era of optogenetics: from the central to peripheral nervous system

Abstract

Optogenetics has recently gained recognition as a biological technique to control the activity of cells using light stimulation. Many studies have applied optogenetics to cell lines in the central nervous system because it has the potential to elucidate neural circuits, treat neurological diseases and promote nerve regeneration. There have been fewer studies on the application of optogenetics in the peripheral nervous system. This review introduces the basic principles and approaches of optogenetics and summarizes the physiology and mechanism of opsins and how the technology enables bidirectional control of unique cell lines with superior spatial and temporal accuracy. Further, this review explores and discusses the therapeutic potential for the development of optogenetics and its capacity to revolutionize treatment for refractory epilepsy, depression, pain, and other nervous system disorders, with a focus on neural regeneration, especially in the peripheral nervous system. Additionally, this review synthesizes the latest preclinical research on optogenetic stimulation, including studies on non-human primates, summarizes the challenges, and highlights future perspectives. The potential of optogenetic stimulation to optimize therapy for peripheral nerve injuries (PNIs) is also highlighted. Optogenetic technology has already generated exciting, preliminary evidence, supporting its role in applications to several neurological diseases, including PNIs.     

Specific RNase isoenzymes in the human central nervous system

After inactivation of RNase inhibitor by parachloromercuribenzoate, total alkaline RNase activity was found to be two fold higher in white matter as in grey matter extracts from human brain tissue. This activity was lower in human purified myelin. Two human cerebrospinal fluid (CSF) RNase isoenzymes of group 3 (a minor one, RNase 3.1, and a major one, RNase 3.2) were found to be present in human grey and white matter extracts and in purified myelin, but absent in human serum, peripheral nerve, liver, and spleen extracts. A RNase isoenzyme similar to central nervous system (CNS) RNase 3.2 was present in human kidney extracts but it differed in its carbohydrate structure. RNase isoenzymes 3.1 and 3.2 were not found in mouse, rat, and bovine brains. Thus, RNases 3.1 and 3.2 seem specific to human CNS. RNases of group 3 are the predominant RNase isoenzymes in CSF and one of the two predominant RNase groups in brain tissue. However, the proportion of RNases of group 3 is different in CSF and in brain extracts: RNases 3.1-3.2 are the major constituents of group 3 RNases in brain tissue, while another RNase isoenzyme of group 3, RNase 3.0, which is more glycosylated than RNases 3.1-3.2, is only a minor part of RNase of group 3 in brain extracts. Conversely, RNases 3.1-3.2 are lower or equivalent to RNase 3.0 in control CSF since the ratio of RNases 3.1-3.2 to RNase 3.0 did not exceed 1.0. This ratio decreased in pathological CSF including multiple sclerosis or infectious CNS diseases that were free of transudation phenomena. In conclusion, CSF RNases 3.1-3.2 seem to originate in brain tissue and could be markers of RNA catabolism from brain cells.